Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Impact of screening on incidence and mortality of prostate cancer in the United States.

Potosky AL, Feuer EJ, Levin DL.

Epidemiol Rev. 2001;23(1):181-6. Review.

PMID:
11588846
2.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
3.

Impact of screening on prostate cancer rates and trends.

Mettlin C.

Microsc Res Tech. 2000 Dec 1;51(5):415-8. Review.

PMID:
11074610
4.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
5.
6.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
7.
8.

Screening for prostate cancer: current recommendations.

Wilson SS, Crawford ED.

Urol Clin North Am. 2004 May;31(2):219-26. Review.

PMID:
15123402
9.

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

Lim LS, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2008 Feb;34(2):164-70. doi: 10.1016/j.amepre.2007.10.003. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454.

PMID:
18201648
10.

Prostate cancer screening: promise and peril--a review.

Godley PA.

Cancer Detect Prev. 1999;23(4):316-24. Review.

PMID:
10403903
11.

[Advancements in PSA-based screening for prostate cancer].

Ito K.

Rinsho Byori. 2004 Jul;52(7):611-7. Review. Japanese.

PMID:
15344561
12.

International epidemiology of prostate cancer: geographical distribution and secular trends.

Baade PD, Youlden DR, Krnjacki LJ.

Mol Nutr Food Res. 2009 Feb;53(2):171-84. doi: 10.1002/mnfr.200700511. Review.

PMID:
19101947
13.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
14.
15.
16.

[Descriptive epidemiology of prostate cancer in Japan and Western countries].

Wakai K.

Nihon Rinsho. 2005 Feb;63(2):207-12. Review. Japanese.

PMID:
15714967
17.

PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?

Crawford ED, Abrahamsson PA.

Eur Urol. 2008 Aug;54(2):262-73. doi: 10.1016/j.eururo.2008.05.032. Epub 2008 May 27. Review.

PMID:
18556114
18.

Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

Wilt TJ.

Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.

PMID:
11828353
19.

Epidemiology of prostate cancer.

Crawford ED.

Urology. 2003 Dec 22;62(6 Suppl 1):3-12. Review.

PMID:
14706503
20.

The epidemiology of prostate cancer in the United States.

Brawley OW, Barnes S.

Semin Oncol Nurs. 2001 May;17(2):72-7. Review.

PMID:
11383246

Supplemental Content

Support Center